Related content

Tuberculosis susceptibility – implications for drug development and therapy

By Snell Noel J C  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 9, 2003-09 ,pp. : 1455-1460

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics: Integration into Drug Discovery and Development

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-09 ,pp. : 1039-1046

Bentham Science Publishers

Access to resources Recommend Favorite

The discovery and development of perampanel for the treatment of epilepsy

By Hanada Takahisa  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 4, 2014-04 ,pp. : 449-458

Informa Healthcare

Access to resources Recommend Favorite

The preclinical discovery and development of ezogabine for the treatment of epilepsy

By Jankovic Slobodan   Ilickovic Ivana  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1429-1437

Informa Healthcare

Access to resources Recommend Favorite

Drug-Target Pharmacogenomics: The potential to revolutionize drug discovery and development

By  

Pharmaceutical Innovation, Vol. 11, Iss. 4, 2002-06 ,pp. : 30-37

Adis International

Access to resources Recommend Favorite